812
Views
1
CrossRef citations to date
0
Altmetric
Portrait

From plant virology to vaccinology: The road less travelled

References

  • Rybicki EP: Maize Streak Virus – an African Pathogen Come Home. S Afr J Sci 1988, 84(1):30-32.
  • Williamson AL, Rybicki EP: Detection of Genital Human Papillomaviruses by Polymerase Chain-Reaction Amplification with Degenerate Nested Primers. J Med Virol 1991, 33(3):165-171.
  • Williamson AL, Brink NS, Dehaeck CMC, Ovens S, Soeters R, Rybicki EP: Typing of Human Papillomaviruses in Cervical-Carcinoma Biopsies from Cape-Town. J Med Virol 1994, 43(3):231-237.
  • Ramesar JE, Rybicki EP, Williamson AL: Sequence Variation in the L1 Gene of Human Papillomavirns Type-16 from Africa. Arch Virol 1995, 140(10):1863-1870.
  • van Harmelen J, Wood R, Lambrick M, Rybicki EP, Williamson AL, Williamson C: An association between HIV-1 subtypes and mode of transmission in Cape Town, South Africa. Aids 1997, 11(1):81-87.
  • Hackland AF, Coetzer CT, Rybicki EP, Thomson JA: Genetically engineered resistance in tobacco against South African strains of tobacco necrosis and cucumber mosaic viruses. S Afr J Sci 2000, 96(1):33-38.
  • Palmer KE, Rybicki EP: The use of geminiviruses in biotechnology and plant molecular biology, with particular focus on Mastreviruses. Plant Sci 1997, 129(2):115-130.
  • Palmer KE, Thomson JA, Rybicki EP: Generation of maize cell lines containing autonomously replicating maize streak virus-based gene vectors. Arch Virol 1999, 144(7):1345-1360.
  • Palmer KE, Rybicki EP: Investigation of the potential of Maize streak virus to act as an infectious gene vector in maize plants. Arch Virol 2001, 146(6):1089-1104.
  • Varsani A, Williamson AL, Rose RC, Jaffer M, Rybicki EP: Expression of Human papillomavirus type 16 major capsid protein in transgenic Nicotiana tabacum cv. Xanthi. Arch Virol 2003, 148(9):1771-1786.
  • Kohl T, Hitzeroth II, Stewart D, Varsani A, Govan VA, Christensen ND, Williamson AL, Rybicki EP: Plant-produced cottontail rabbit papillomavirus L1 protein protects against tumor challenge: a proof-of-concept study. Clin Vaccine Immunol 2006, 13(8):845-853.
  • Varsani A, Williamson AL, Stewart D, Rybicki EP: Transient expression of Human papillomavirus type 16 L1 protein in Nicotiana benthamiana using an infectious tobamovirus vector. Virus Res 2006, 120(1–2):91-96.
  • Varsani A, Williamson AL, de Villiers D, Becker I, Christensen ND, Rybicki EP: Chimeric human papillomavirus type 16 (HPV-16) L1 particles presenting the common neutralizing epitope for the L2 minor capsid protein of HPV-6 and HPV-16. J Virol 2003, 77(15):8386-8393.
  • Maclean J, Koekemoer M, Olivier AJ, Stewart D, Hitzeroth II, Rademacher T, Fischer R, Williamson AL, Rybicki EP: Optimization of human papillomavirus type 16 (HPV-16) L1 expression in plants: comparison of the suitability of different HPV-16 L1 gene variants and different cell-compartment localization. J Gen Virol 2007, 88:1460-1469.
  • Jaffray A, Shephard E, van Harmelen J, Williamson C, Williamson AL, Rybicki EP: Human immunodeficiency virus type 1 subtype C Gag virus-like particle boost substantially improves the immune response to a subtype C gag DNA vaccine in mice. J Gen Virol 2004, 85:409-413.
  • Halsey RJ, Tanzer FL, Meyers A, Pillay S, Lynch A, Shephard E, Williamson AL, Rybicki EP: Chimaeric HIV-1 subtype C Gag molecules with large in-frame C-terminal polypeptide fusions form virus-like particles. Virus Res 2008, 133(2):259-268.
  • Pillay S, Meyers A, Williamson AL, Rybicki EP: Optimization of Chimeric HIV-1 Virus-Like Particle Production in a Baculovirus-Insect Cell Expression System. Biotechnol Progr 2009, 25(4):1153-1160.
  • Lynch A, Meyers AE, Williamson AL, Rybicki EP: Stability studies of HIV-1 Pr55(gag) virus-like particles made in insect cells after storage in various formulation media. Virol J 2012, 9.
  • Chege GK, Shephard EG, Meyers A, van Harmelen J, Williamson C, Lynch A, Gray CM, Rybicki EP, Williamson AL: HIV-1 subtype CPr55(gag) virus-like particle vaccine efficiently boosts baboons primed with a matched DNA vaccine. J Gen Virol 2008, 89:2214-2227.
  • Chege GK, Burgers WA, Stutz H, Meyers AE, Chapman R, Kiravu A, Bunjun R, Shephard EG, Jacobs WR, Rybicki EP et al: Robust Immunity to an Auxotrophic Mycobacterium bovis BCG-VLP Prime-Boost HIV Vaccine Candidate in a Nonhuman Primate Model. J Virol 2013, 87(9):5151-5160.
  • Rybicki EP, Williamson AL, Meyers A, Hitzeroth II: Vaccine farming in Cape Town. Hum Vaccines 2011, 7(3):339-348.
  • Meyers A, Chakauya E, Shephard E, Tanzer FL, Maclean J, Lynch A, Williamson AL, Rybicki EP: Expression of HIV-1 antigens in plants as potential subunit vaccines. Bmc Biotechnol 2008, 8.
  • Tanzer FL, Shephard EG, Palmer KE, Burger M, Williamson AL, Rybicki EP: The porcine circovirus type 1 capsid gene promoter improves antigen expression and immunogenicity in a HIV-1 plasmid vaccine. Virol J 2011, 8.
  • Burgers WA, Chege GK, Muller TL, van Harmelen JH, Khoury G, Shephard EG, Gray CM, Williamson C, Williamson AL: Broad, high-magnitude and multifunctional CD4+ and CD8+ T-cell responses elicited by a DNA and modified vaccinia Ankara vaccine containing human immunodeficiency virus type 1 subtype C genes in baboons. J Gen Virol 2009, 90(Pt 2):468-480.
  • Burgers WA, Shephard E, Monroe JE, Greenhalgh T, Binder A, Hurter E, Van Harmelen JH, Williamson C, Williamson AL: Construction, characterization, and immunogenicity of a multigene modified vaccinia Ankara (MVA) vaccine based on HIV type 1 subtype C. AIDS Res Hum Retroviruses 2008, 24(2):195-206.
  • Mortimer E, Maclean JM, Mbewana S, Buys A, Williamson AL, Hitzeroth II, Rybicki EP: Setting up a platform for plant-based influenza virus vaccine production in South Africa. Bmc Biotechnol 2012, 12.
  • Mortimer E, Hitzeroth II, Buys A, Mbewana S, Rybicki EP: An H5N1 influenza DNA vaccine for South Africa. S Afr J Sci 2013, 109(9-10).
  • Thuenemann EC, Meyers AE, Verwey J, Rybicki EP, Lomonossoff GP: A method for rapid production of heteromultimeric protein complexes in plants: assembly of protective bluetongue virus-like particles. Plant Biotechnol J 2013, 11(7):839-846.
  • Pineo CB, Hitzeroth II, Rybicki EP: Immunogenic assessment of plant-produced human papillomavirus type 16 L1/L2 chimaeras. Plant Biotechnol J 2013, 11(8):964-975.
  • Whitehead M, Ohlschlager P, Almajhdi FN, Alloza L, Marzabal P, Meyers AE, Hitzeroth II, Rybicki EP: Human papillomavirus (HPV) type 16 E7 protein bodies cause tumour regression in mice. Bmc Cancer 2014, 14.
  • Regnard GL, Halley-Stott RP, Tanzer FL, Hitzeroth II, Rybicki EP: High level protein expression in plants through the use of a novel autonomously replicating geminivirus shuttle vector. Plant Biotechnol J 2010, 8(1):38-46.
  • Duvenage L, Hitzeroth II, Meyers AE, Rybicki EP: Expression in tobacco and purification of beak and feather disease virus capsid protein fused to elastin-like polypeptides. J Virol Methods 2013, 191(1):55-62.
  • Regnard GL, Boyes RS, Martin RO, Hitzeroth II, Rybicki EP: Beak and feather disease viruses circulating in Cape parrots (Poicepahlus robustus) in South Africa. Arch Virol 2015, 160(1):47-54.
  • Walwyn DR, Huddy SM, Rybicki EP: Techno-Economic Analysis of Horseradish Peroxidase Production Using a Transient Expression System in Nicotiana benthamiana. Appl Biochem Biotech 2015, 175(2):841-854.
  • Rybicki EP: Plant-based vaccines against viruses. Virol J 2014, 11.
  • Rybicki EP, Hitzeroth II, Meyers A, Santos MJD, Wigdorovitz A: Developing Country Applications of Molecular Farming: Case Studies in South Africa and Argentina. Curr Pharm Design 2013, 19(31):5612-5621.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.